SCHEMBL8100254

SCHEMBL8100254

CCOC(=O)CCC(O)C(=O)OCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.55
KMT2A Q03164 2/20 0.51
POLB P06746 2/20 0.51
CYP1A2 P05177 1/20 0.47
GAA P10253 2/20 0.46
MGAM O43451 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
ALDH1A1 P00352 6/20 0.43
TRPA1 O75762 1/20 0.43
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
NR1I2 O75469 1/20 0.38
PGR P06401 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
PTGS2 P35354 1/20 0.38
PDE4D Q08499 1/20 0.38
HSD17B10 Q99714 3/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3019317 0.88 L3MBTL1 (0.47) L3MBTL1KMT2APOLBCYP1A2GAA
SCHEMBL15154015 0.88 CYP1A2 (0.53) L3MBTL1KMT2APOLBCYP1A2GAA
SCHEMBL28815040 0.88 CYP1A2 (0.53) L3MBTL1KMT2APOLBCYP1A2GAA
SCHEMBL27710501 0.88 L3MBTL1 (0.51) L3MBTL1KMT2APOLBCYP1A2GAA
SCHEMBL29779780 0.88 CYP1A2 (0.53) L3MBTL1KMT2APOLBCYP1A2GAA
SCHEMBL12190162 0.86 CYP1A2 (0.52) L3MBTL1KMT2APOLBCYP1A2GAA
SCHEMBL27871507 0.85 TET2 (0.52) L3MBTL1KMT2APOLBCYP1A2GAA
SCHEMBL28869250 0.85 L3MBTL1 (0.49) L3MBTL1KMT2APOLBCYP1A2GAA
SCHEMBL28343057 0.84 KMT2A (0.53) L3MBTL1KMT2APOLBCYP1A2GAA
SCHEMBL15154065 0.84 KMT2A (0.53) L3MBTL1KMT2APOLBCYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115947659-A Vegetable oil polyalcohol as well as preparation method and application thereof 张家港市飞航科技有限公司 2023-04-11 CN claimed
CN-115754085-A Kit, method, system and terminal for detecting sensitivity of tumor cells to RSL3 复旦大学附属中山医院 2023-03-07 CN claimed
US-8874019-B2 Image forming method KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2014-10-28 US claimed
US-20130202336-A1 IMAGE FORMING METHOD KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2013-08-08 US claimed
CN-101805756-B Biological catalysis method for preparing statin medicinal intermediate UNIV ZHEJIANG TECHNOLOGY 2013-06-19 CN claimed
US-20260033524-A1 FLAVOR MODIFYING COMPOSITIONS CORN PRODUCTS DEV INC (US) 2026-02-05 US disclosed
EP-4561366-A1 FLAVOR MODIFYING COMPOSITION CORN Products Development Inc. (US) 2025-06-04 EP disclosed
CN-119866889-A Method for producing fragrant style tobacco leaves 福建中烟工业有限责任公司 2025-04-25 CN disclosed
CN-119894387-A Flavor modulating composition 玉米产品开发公司 2025-04-25 CN disclosed
US-20250081996-A1 FLAVOR MODIFYING COMPOSITION PURECIRCLE SDN BHD (MY) 2025-03-13 US disclosed
CN-119340456-A Preparation method and application of sodium-ion double-layer solid electrolyte of sodium-ion battery 浙江华宇钠电新能源科技有限公司 2025-01-21 CN disclosed
CN-115947659-B Vegetable oil polyol and preparation method and application thereof 张家港市飞航科技有限公司 2024-11-15 CN disclosed
WO-2018109464-A1 MODIFYING OR ENHANCING A FLAVOR OF FOOD AND BEVERAGE PRODUCTS TATE & LYLE INGREDIENTS AMERICAS LLC (US) 2018-06-21 WO disclosed
EP-1874407-B1 SUBSTANCES AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF GLYOXALASES AND THEIR USE AS ANTI-FUNGAL AGENTS BIOMAC PRIVATINSTITUT FÜR MEDIZINISCHE UND ZAHNMEDIZINISCHE FORSCHUNG ENTWICKLUNG UND DIAGNOSTIK GMB (DE) 2015-09-09 EP disclosed
US-8874019-B2 Image forming method KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2014-10-28 US disclosed
US-20130202336-A1 IMAGE FORMING METHOD KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2013-08-08 US disclosed
EP-1877141-B1 SUBSTANCES AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF GLYOXALASES AND THEIR USE AGAINST BACTERIA BIOMAC PRIVATINSTITUT FUER MEDIZINISCHE UND ZAHNMEDIZINISCHE FORSCHUNG ENTWICKLUNG UND DIAGNOSTIK GM (DE) 2013-06-12 EP disclosed
US-6037444-A COMPOUND OR POLYMER HAVING THIOL, HYDROXY, AMINO OR CARBOXYLIC GROUP IS REACTED WITH A COMPOUND COMPRISING AT LEAST TWO FUNCTIONAL GROUPS SELECTED FROM HYDROXYL, THIOL, AMINO AND CARBOXYLIC ACID GROUPS WHICH FUNCTIONAL GROUPS COURTAULDS COATINGS (HOLDINGS) LIMITED (GB) 2000-03-14 US disclosed
EP-0888279-A1 SELECTIVE CHEMICAL REACTIONS AND POLYMERS OF CONTROLLED ARCHITECTURE PRODUCED THEREBY COURTAULDS COATINGS (HOLDINGS) LIMITED (GB) 1999-01-07 EP disclosed
WO-1997023443-A1 SELECTIVE CHEMICAL REACTIONS AND POLYMERS OF CONTROLLED ARCHITECTURE PRODUCED THEREBY COURTAULDS COATINGS (HOLDINGS) LIMITED (GB) 1997-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260033524-A1 FLAVOR MODIFYING COMPOSITIONS TAS2R42, TAS2R7, TAS2R31 L3MBTL1 2420/4885KMT2A 3706/4885POLB 4255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.